Operating Lease, Right-of-Use Asset of Oncology Institute, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Oncology Institute, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Oncology Institute, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $23,265,000, a 14% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Oncology Institute, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $23,265,000 -$3,818,000 -14% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $23,887,000 -$3,105,000 -12% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $24,209,000 -$3,207,000 -12% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $25,782,000 -$3,387,000 -12% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $27,083,000 -$1,450,000 -5.1% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $26,992,000 -$2,049,000 -7.1% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $27,416,000 +$2,738,000 +11% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $29,169,000 +$4,675,000 +19% 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q3 2023 $28,533,000 +$3,725,000 +15% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $29,041,000 +$11,786,000 +68% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $24,678,000 +$7,445,000 +43% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $24,494,000 +$24,494,000 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $24,808,000 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $17,255,000 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $17,233,000 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $0 31 Dec 2021 10-K 16 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.